TrialInternational journal of chronic obstructive pulmonary disease2015

The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.

Alberto Papi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.